Navidea to sell $8M milestone payment

Navidea Biopharmaceuticals plans to sell an $8 million milestone paymen...Read more on AuntMinnie.comRelated Reading: Navidea posts deep Q3 revenue decreases Navidea posts revenue declines, net loss increases in Q2 Navidea highlights research on melanoma, oral cancer Navidea touts clinical study using PET/CT for HIV infection Navidea touts early results of RA study

https://www.auntminnie.com/redirect/redirect.aspx?itemid=139972&wf=1

Source: AuntMinnie.com Headlines - April 28, 2023 Category: Radiology Source Type: news